Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene Panel Testing in Hereditary Breast Cancer.

Archives of Iranian medicine - 1 Mar 2020

Rostami Parvin, Zendehdel Kazem, Shirkoohi Reza, Ebrahimi Elmira, Ataei Mitra, Imanian Hashem, Najmabadi Hossein, Akbari Mohammad Reza, Sanati Mohammad Hossein

Abstract excerpt

BACKGROUND: Breast cancer (BC) is a highly complex, heterogeneous and multifactorial disease and is the most commonly diagnosed cancer and the leading cause of cancer-related mortality in women worldwide. Family history and genetic mutations are important risk factors for BC. While studies in twins have estimated that about 10%-30% of BC are due to hereditary factors, only 4%-5% of them are due to mutations in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Genetic Predisposition to Disease

Share to Germ-Line Mutation

Share to High-Throughput Nucleotide Sequencing

Source

Identifiers

PMID: 32126783

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene Panel Testing in Hereditary Breast Cancer.PMID 32126783Read ↗

Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes.Semantic proximity Read ↗

Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.Semantic proximity Read ↗

A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genesSemantic proximity Read ↗

Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer.Semantic proximity Read ↗

Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.Semantic proximity Read ↗

Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.Semantic proximity Read ↗

Mutational profile of hereditary breast and ovarian cancer - Establishing genetic testing guidelines in a developing country.Semantic proximity Read ↗

Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controlsSemantic proximity Read ↗

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.Semantic proximity Read ↗

What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database.Semantic proximity Read ↗

Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test Panel.Semantic proximity Read ↗

Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.